CTEP

Results: 314



#Item
41Barry Anderson, a member of CTEP, requested the consult to discuss a proposed phase III trial of G-CSF stimulated bone marrow

Barry Anderson, a member of CTEP, requested the consult to discuss a proposed phase III trial of G-CSF stimulated bone marrow

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2008-11-21 14:10:27
42National Institutes of Health / National Cancer Institute / Point-to-Point Tunneling Protocol / The Cancer Genome Atlas / Medicine / Cancer organizations / Cancer research

MATERIAL TRANSFER AGREEMENT The NCI-supported Pediatric Preclinical Testing Program (PPTP) is a comprehensive program to systematically evaluate new agents against childhood solid tumor and leukemia models. The PPTP is

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2013-09-17 22:06:52
43Background: The Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) is currently supplying the ch14.18 monoclonal antibody only for patients enrolled on ANBL0032 and ANBL0931. All patients enr

Background: The Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) is currently supplying the ch14.18 monoclonal antibody only for patients enrolled on ANBL0032 and ANBL0931. All patients enr

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2012-03-18 20:03:48
44Bethesda /  Maryland / Cancer research / Nursing research / Hepatocellular carcinoma / Medicine / Health / National Institutes of Health

DOC Document

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2011-04-12 13:11:51
45Law / Trade secret / Confidentiality / Private law / Law of agency / Non-disclosure agreement / Secrecy / Ethics / Intellectual property law

CONFIDENTIAL DISCLOSURE AGREEMENT This Agreement is made by and between the National Cancer Institute, an agency of the United States Government (hereinafter referred to as “NCI”), and (insert name of company), an en

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2013-09-17 22:06:52
46Pharmaceutical Management Branch Cancer Therapy Evaluation Program, DCTD, NCI Policy and Guidelines for INVESTIGATIONAL AGENT DISTRIBUTION Policy:

Pharmaceutical Management Branch Cancer Therapy Evaluation Program, DCTD, NCI Policy and Guidelines for INVESTIGATIONAL AGENT DISTRIBUTION Policy:

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2014-08-03 15:40:28
47Clinical research / Pharmacology / Cancer organizations / Clinical trial / Design of experiments / Pharmaceutical industry / Neuroblastoma / Leukemia / Medicine / Health / Oncology

Non-Protocol Access to Experimental Agents NCI provides experimental anti-cancer agents for children and adults with cancer primarily through clinical trials sponsored by the Cancer Therapy Evaluation Program (CTEP). O

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2009-03-15 22:28:23
48Clinical research / Food and Drug Administration / Pharmaceutical industry / Drug safety / Nursing research / Cooperative Research and Development Agreement / National Renewable Energy Laboratory / Investigational New Drug / Clinical investigator / Research / Medicine / Health

PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR NCI DIVISION OF CANCER TREATMENT AND DIAGNOSIS (DCTD) EXTRAMURAL PHS CLINICAL RESEARCH This Agreement is based on the model Cooperative Research

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2013-09-17 22:06:52
49Health / Medicine / Pharmaceutical industry / Drug safety / Medical statistics / Investigational New Drug / Clinical trial / New Drug Application / Clinical research / Research / Food and Drug Administration

Appendix A: Research Plan Title of CRADA Clinical Development of Collaborator’s Proprietary Compound (Agent Name), Agent Class, as an Anti-Cancer Agent NIH CRADA Extramural Investigator/Officer(s)

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2013-09-17 22:06:51
50Patent law / Technology transfer / Civil law / United States patent law / 96th United States Congress / Bayh–Dole Act / Patent / Royalties / Title 35 of the United States Code / Law / Intellectual property law / Technology

MATERIAL TRANSFER AGREEMENT Provider: Division of Cancer Treatment and Diagnosis, National Cancer Institute Recipient: University School of Medicine

Add to Reading List

Source URL: ctep.cancer.gov

Language: English - Date: 2013-09-17 22:06:52